Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Nature Communications|January 28, 2022
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infectionsLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|August 9, 2022
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineageHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Scientific Reports|June 5, 2021
Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence populationGheyath K Nasrallah, Soha R Dargham, Farah Shurrab, et al.
Journal of Global Health|February 9, 2022
Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar's experienceRaghid Bsat, Hiam Chemaitelly, Peter Coyle, et al.
Plos Medicine|December 16, 2021
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort studyLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Influenza and Other Respiratory Viruses|November 29, 2023
SARS-CoV-2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort studyMai A Mahmoud, Houssein H Ayoub, Peter Coyle, et al.
Nature Communications|June 2, 2022
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in QatarHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
The New England Journal of Medicine|October 6, 2021
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in QatarHiam Chemaitelly, Patrick Tang, Mohammad R Hasan, et al.
Science Advances|October 4, 2023
History of primary-series and booster vaccination and protection against Omicron reinfectionHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
Ebiomedicine|July 29, 2023
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational studyHeba N Altarawneh, Hiam Chemaitelly, Houssein H Ayoub, et al.
Pageof 19